Patents by Inventor Stephan A. Grupp

Stephan A. Grupp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7026330
    Abstract: Methods for treating patients having an early B cell derived acute lymphoblastic leukemia with rapamycin or a derivative thereof are provided. Also provided are methods for treating patients having an early B cell derived acute lymphoblastic leukemia with rapamycin or a derivative thereof in combination with an IL-7 inhibitor. Finally methods for preventing GVHD in ALL patients following a bone marrow transplant are disclosed.
    Type: Grant
    Filed: May 30, 2003
    Date of Patent: April 11, 2006
    Assignee: The Children's Hospital of Philadelphia
    Inventors: Stephan A. Grupp, Valerie I. Brown
  • Publication number: 20040039010
    Abstract: Methods for treating patients having an early B cell derived acute lymphoblastic leukemia with rapamycin or a derivative thereof are provided. Also provided are methods for treating patients having an early B cell derived acute lymphoblastic leukemia with rapamycin or a derivative thereof in combination with an IL-7 inhibitor. Finally methods for preventing GVHD in ALL patients following a bone marrow transplant are disclosed.
    Type: Application
    Filed: May 30, 2003
    Publication date: February 26, 2004
    Inventors: Stephan A. Grupp, Valerie I. Brown
  • Publication number: 20030100605
    Abstract: Disclosed are methods of treating cancer utilizing angiogenesis inhibitors as an adjunct to high-dose therapy and stem cell rescue.
    Type: Application
    Filed: May 15, 2002
    Publication date: May 29, 2003
    Inventor: Stephan A. Grupp